Health News Releases

July 02, 2014 17:20

COPD: Boehringer Ingelheim submits applications in Europe for tiotropium + olodaterol Respimat® fixed-dose combination in COPD

For media outside the US, the UK and Canada Boehringer Ingelheim today announced submission of Marketing Authorisation Applications in 31 European countries for the once-daily fixed-dose combinatio

July 02, 2014 13:55

Quintiles Completes Acquisition of Encore Health Resources

Quintiles today announced that it has completed the acquisition (http://goo.gl/bq5JiK) of Encore Health Resources (Encore, http://encorehealthresources.com), a leader in the health-information analyti

July 02, 2014 11:15

World Bank-Aided GNRC Plans Launch of Medi-Chopper Service in North-East India

GNRC (formerly known as Guwahati Neurological Research Centre) today unveiled plans to initiate air ambulance and medical outreach programme using helicopters to remote areas of North-east India. The

July 01, 2014 12:00

Quintiles’ Second Quarter 2014 Earnings Call Scheduled for Thursday, July 31st

Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the second quarter of 2014 prior to its quarterly earnings call on Thursday, July 31, 2014, at 8:00 a.m. EDT.

July 01, 2014 11:45

U.S. FDA grants Breakthrough Therapy Designation to Pradaxa® (dabigatran etexilate) specific investigational antidote

For media outside of the U.S., the UK & Canada only The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational antidote idarucizumab* (a humaniz

July 01, 2014 11:40

CHMP Recommends EU Approval of VIZAMYL™ (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque

GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). This opinion recommends the granting of a ma

June 25, 2014 18:00

China to Host World’s Largest Integrated Health Industry Event “tHIS” in 2015

Reed Sinopharm Exhibitions, the leading healthcare event organizer in China, announced Wednesday the launch of The Health Industry Summit (tHIS, www.thishealthsummit.com) in Shanghai. This new event,

June 25, 2014 14:08

Fast-Evolving US Cardiac Ablation Industry Affords Multiplying Niche Opportunities, Says Frost & Sullivan

The increasing prevalence of cardiac arrhythmias and availability of premium-priced innovative technologies are driving the cardiac ablation market in the U.S. Promising technologies, including balloo

June 25, 2014 11:25

ADEA to Host 5th International Women’s Leadership Conference along with International Workshop, Sept. 14-16, 2014

The American Dental Education Association (ADEA, www.adea.org), the premier association serving the dental education community, is hosting two meetings for today’s globally-minded dental education and

June 24, 2014 17:45

Ferring Pharmaceuticals and Roche collaborate to develop personalised infertility treatment

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring’s human cell line derived recombinant follicle-stimulating hormone (hu

June 24, 2014 10:30

Quintiles Named a Best IT Workplace by Computerworld

Quintiles, the world’s largest biopharmaceutical services provider and a Fortune 500 company, has been named one of IDG Computerworld's 100 Best Places to Work in IT 2014 (www.computerworld.com), the

June 20, 2014 17:30

New Pradaxa® clinical study to explore practical management of patients with atrial fibrillation undergoing ablation

For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announces a new study of Pradaxa® (dabigatran etexilate) in patients with atrial fibrillation (AF). The RE-CIRCUIT™ st

June 20, 2014 11:35

Quintiles and Modern Marketing Concepts Collaborate to Launch Innovative Marketing Analytics Platform

Quintiles (www.quintiles.com) and Modern Marketing Concepts (MMC, Inc., www.mmcweb.com) today announced the launch of a new marketing analytics platform that enables Quintiles to optimize sales and ma

June 18, 2014 12:05

Pathway Genomics Co-Hosts Fundraiser Benefiting Susan G. Komen

Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, last week co-hosted a fundraiser benefiting Susan G. Komen. J

June 17, 2014 13:15

Type 2 Diabetes: Jardiance® (empagliflozin) as an add-on therapy significantly reduced blood glucose and body weight in two newly presented Phase III trials

For Non-U.S. and Non-U.K. Media Boehringer Ingelheim and Eli Lilly and Company presented results of two Phase III clinical trials studying the efficacy and safety of empagliflozin, a sodium glucose

June 16, 2014 18:45

22nd Century Group to be Added to Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes

22nd Century Group, Inc. (NYSE MKT: XXII, http://finance.yahoo.com/q?s=xxii) today announced that the Company will join the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes when

June 16, 2014 16:35

New survey in five European countries reveals urgent need to improve education about Acute Myeloid Leukaemia

For media outside of the US/UK only Acute myeloid leukaemia (AML) is a devastating form of blood cancer that mainly affects people over 60 years old.[1] For older patients who receive chemotherapy,

June 16, 2014 14:10

Oral OTEZLA® (Apremilast) Monotherapy Showed Long-Term Clinical Benefits in DMARD-Naïve Patients with Active Psoriatic Arthritis

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced results from a long-term (52-week) phase III trial of OTEZLA, the Company’s oral, selective

June 16, 2014 14:05

Oral OTEZLA® (Apremilast) Showed Long-Term Clinical Benefits in Patients with Active Psoriatic Arthritis

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced results of additional analyses from the phase III clinical trials of OTEZLA, the Company’s o

June 16, 2014 01:05

Type 2 Diabetes: Physicians worldwide agree early conversations are crucial in the management of condition

Non-US and Non-UK The first insights from IntroDia™ presented at the American Diabetes Association's (ADA) 74th Scientific Sessions®, showed that over three quarters (76-100 percent across 26 count

June 12, 2014 14:55

U.S. Patent Allowed For 22nd Century Group’s Technology to Regulate Nicotine Levels in Tobacco

22nd Century Group, Inc. (NYSE MKT:XXII) today announced that on June 9, 2014 the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance to the Company for technology that reduces nicot

June 10, 2014 15:55

Diabetes: Boehringer Ingelheim and Eli Lilly and Company Alliance to have 43 Presentations Featured at the American Diabetes Association’s 74th Scientific Sessions®

For Non-US and Non-UK Media More than 40 presentations including posters, abstracts and oral presentations will demonstrate the breadth and depth of the Boehringer Ingelheim (BI) and Eli Lilly and

June 10, 2014 14:00

Quintiles Named ‘Overwhelming Leader’ in Phase I Market Report

For the second year in a row, Quintiles has been named the CRO industry leader in Phase I services according to respondents in Industry Standard Research’s (ISR) report, CRO Quality Benchmarking Phase

June 09, 2014 14:25

MSD to Present New Clinical Data on Sitagliptin, Investigational Omarigliptin, and Real-World Data in Patients with Type 2 Diabetes at the 74th Scientific Sessions of the American Diabetes Association

MSD, known as Merck (NYSE:MRK) in the United States and Canada, will present 13 new studies and analyses, including data for its DPP-4 inhibitor JANUVIA® (sitagliptin) and for its investigational once

June 09, 2014 13:45

Pradaxa® gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism

For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announces that Pradaxa® (dabigatran etexilate) has been approved by the European Commission for the treatment and prev

News by Region

News by Industry